The rise and fall of IBM Watson Health represents one of the most instructive case studies in the history of enterprise computing, digital health, and clinical informatics. Marketed as a revolutionary breakthrough that would eliminate diagnostic errors and personalise oncology care globally, the enterprise culminated in a multi-billion-dollar strategic retreat, the cancellation of flagship academic partnerships, and the eventual liquidation of its assets. The collapse was no

The global healthcare ecosystem is currently traversing a structural inflection point where the traditional metrics of enterprise value, physical infrastructure, patient volume, and legacy software interfaces, are being systematically superseded by the strategic accumulation and utilisation of proprietary health data. In the current mergers and acquisitions landscape of 2024 and 2025, data has transitioned from a passive byproduct of clinical operations into a primary soverei

The global healthcare ecosystem is currently navigating a period of profound re-architecting, driven by the convergence of massive digital health data repositories and the unprecedented reasoning capabilities of Large Language Models (LLMs). This transition represents a departure from traditional, rule-based clinical decision support systems toward dynamic, generative architectures capable of interpreting the vast complexities of human physiology and clinical narrative. The